Atezolizumab and bevacizumab with anticoagulant or antiplatelet therapy in hepatocellular carcinoma patients: Real-world data for informed clinical decision-making.
François VilleretPierre NahonPublished in: Liver international : official journal of the International Association for the Study of the Liver (2024)